Design, Synthesis, and Biological Evaluation of New PDE4 Inhibitors for the Treatment of Pressure Ulcers

Pressure ulcers (PU) are an inflammatory skin disease that causes localized tissue ulceration and ischemic necrosis. In this work, a new series of PDE4 inhibitors were designed and synthesized for the treatment of PU. Potential compound <b>G1</b> exhibited an IC<sub>50</sub> value of 29 nM against PDE4D and inhibited the production of TNF-α (IC<sub>50</sub> = 13.32 μM) and NO (IC<sub>50</sub> = 2.32 μM). In a rat PU model, <b>G1</b> exhibited the capability to reduce the expression levels of inflammatory markers in skin tissue, diminish the thickness of the epidermal layer, decrease the number of dermal inflammatory cells, and significantly enhance the quantity of fibroblasts, which effectively expedited the wound healing process. Furthermore, <b>G1</b> exhibited analgesic effects by increasing the pain threshold under hot plate tests, which may find varying possible applications in the clinic. These results imply that the new PDE4 inhibitor <b>G1</b> is a promising therapeutic option for PU.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-05-27
DOI
https://doi.org/10.1021/acs.jmedchem.5c00505
Citations
2
Primary Topic
Phosphodiesterase function and regulation
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design, Synthesis, and Biological Evaluation of New PDE4 Inhibitors for the Treatment of Pressure Ulcers

Liang‐Chieh Chen, Wei Pan, Yanghui Ou, Dengqin He et al.
2 citations
Journal of Medicinal Chemistry
Phosphodiesterase function and regulation
1.61
article

Design, Synthesis, and Biological Evaluation of New PDE4 Inhibitors for the Treatment of Pressure Ulcers

Liang‐Chieh Chen, Wei Pan, Yanghui Ou, Dengqin He, Xudong Qian, Jiaxin Chen, Yali Zhang, Dandan Chen, Jiayu Li, Liu Y, Mengjie Li, Wenhua Chen, Xu Lang, Hongliang Yao, Yan Geng, Jun Wang, Gang Li
article en
2 citations

Abstract

Pressure ulcers (PU) are an inflammatory skin disease that causes localized tissue ulceration and ischemic necrosis. In this work, a new series of PDE4 inhibitors were designed and synthesized for the treatment of PU. Potential compound <b>G1</b> exhibited an IC<sub>50</sub> value of 29 nM against PDE4D and inhibited the production of TNF-α (IC<sub>50</sub> = 13.32 μM) and NO (IC<sub>50</sub> = 2.32 μM). In a rat PU model, <b>G1</b> exhibited the capability to reduce the expression levels of inflammatory markers in skin tissue, diminish the thickness of the epidermal layer, decrease the number of dermal inflammatory cells, and significantly enhance the quantity of fibroblasts, which effectively expedited the wound healing process. Furthermore, <b>G1</b> exhibited analgesic effects by increasing the pain threshold under hot plate tests, which may find varying possible applications in the clinic. These results imply that the new PDE4 inhibitor <b>G1</b> is a promising therapeutic option for PU.

Journal of Medicinal ChemistryVol. 68(11)
Guangdong Academy of Sciences (CN), Institute of Zoology (CN), Wuyi University (CN)
Special Project for Research and Development in Key areas of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 17%
Phosphodiesterase function and regulation
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.